The study explores whether imaging and tumor biopsy looking for remaining disease can identify melanoma patients who can safely stop immunotherapy treatment early
A gene test helps identify women with high-risk DCIS who will likely benefit from radiation while informing those with low-risk disease about the possibility of safely skipping it